Cellnovo is an innovative medical technology company specialising in diabetes. The company develops and markets The Cellnovo System, the world's first mobile, connected, all-in-one diabetes management system that helps make life easier for people with type 1 diabetes. Compact, intuitive and entirely connected, Cellnovo’s micro-pump for insulin delivery communicates wirelessly with a locked-down Android phone, offering the quality and responsiveness that is to be expected from consumer-grade smartphones, while preserving the high-level of security of a medical-grade device. This unique device allows optimal management of diabetes whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real time.
The current version of the system has received CE Mark approval and is reimbursed and available in 10 countries: France, the United Kingdom, The Netherlands, Italy, Spain, Australia, New Zealand, Israel, Greece and Cyprus. Cellnovo has a clearly-defined expansion strategy that involves accelerating the product’s commercialisation, initially in Europe and then in the United States and Asia, and increasing its production capacity to respond to a high level of demand. For more information, visit www.cellnovo.com.
Location: France, Ile-de-France, Paris
Employees: 51-200
Total raised: $77.1M
Founded date: 2002
Investors 4
Date | Name | Website |
- | Auriga Par... | auriga.vc |
- | Forbion | forbion.co... |
- | Andera Par... | anderapart... |
- | Advent Lif... | adventls.c... |
Funding Rounds 3
Date | Series | Amount | Investors |
10.07.2017 | - | $22.79M | - |
16.09.2016 | - | $6.03M | - |
04.02.2011 | Series B | $48.28M | - |
Mentions in press and media 10
Date | Title | Description | Source |
02.04.2024 | Gilbane, Inc. Announces Appointment of William F. McKeon to ... | William F. McKeon, President & CEO of the Texas Medical Center, joins Gilbane, Inc.'s Board of D... | prweb.com/... |
10.07.2017 | Cellnovo concludes a loan agreement for up to €20 million fr... | The European Investment Bank (EIB) and Cellnovo Group (“Cellnovo” or the “Company” CLNV:EN Paris), a... | forbion.co... |
07.07.2017 | Cellnovo successfully raises € 17.5 million from healthcare ... | Cellnovo Group(“Cellnovo” or the “Company” CLNV:EN Paris), a medical technology company marketing th... | forbion.co... |
16.09.2016 | Cellnovo raises circa EUR 5.4m in capital increase without p... | Cellnovo Group (“Cellnovo” CLNV: EN Paris or the “Company”), a medical technology company marketing ... | forbion.co... |
17.08.2016 | 12 of the Most Exciting Welsh Startups of 2016 | This article was originally posted on the Tech City UK website. Tech Nation 2016 found well over 43... | technation... |
09.02.2012 | Device makers plan to offset tax burden by raising prices | ... | MASSDEVICE ON CALL — Most small medical device companies may deal with the added burden of the impen... | massdevice... |
04.02.2011 | Cellnovo Raises £30M Series B Funding Round | Cellnovo, a London, UK-based developer of a mobile diabetes management system, raised £30m (approxim... | finsmes.co... |
04.02.2011 | Diabetes management system could be ‘iTunes of diabetes care... | Previous investors Advent Venture Partners, HealthCare Ventures and NESTA also participated in the r... | medcitynew... |
04.02.2011 | Cellnovo raises $48 million to commercialize “itunes of diab... | Cellnovo announced its presence as a major player in the diabetes race with $48 million in new fundi... | massdevice... |
- | Diabetes management system could be ‘iTunes of diabetes care... | London-based Cellnovo closes $48 million B round to fund commercialization of the first all mobile d... | medcitynew... |